368 related articles for article (PubMed ID: 24122306)
1. An update on medical therapy for pulmonary arterial hypertension.
Wu Y; O'Callaghan DS; Humbert M
Curr Hypertens Rep; 2013 Dec; 15(6):614-22. PubMed ID: 24122306
[TBL] [Abstract][Full Text] [Related]
2. Riociguat, an oral soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension.
Belik J
Curr Opin Investig Drugs; 2009 Sep; 10(9):971-9. PubMed ID: 19705340
[TBL] [Abstract][Full Text] [Related]
3. Therapies for pulmonary arterial hypertension: where are we today, where do we go tomorrow?
Seferian A; Simonneau G
Eur Respir Rev; 2013 Sep; 22(129):217-26. PubMed ID: 23997048
[TBL] [Abstract][Full Text] [Related]
4. Update on pharmacotherapy for pulmonary hypertension.
Prior DL; Adams H; Williams TJ
Med J Aust; 2016 Sep; 205(6):271-6. PubMed ID: 27627939
[TBL] [Abstract][Full Text] [Related]
5. Recent advances and future perspectives in therapeutic strategies for pulmonary arterial hypertension.
Yao A
J Cardiol; 2012 Nov; 60(5):344-9. PubMed ID: 23068290
[TBL] [Abstract][Full Text] [Related]
6. A Special Focus on Selexipag - Treatment of Pulmonary Arterial Hypertension.
Sorensen LM; Wehland M; Kruger M; Simonsen U; Nassef MZ; Infanger M; Grimm D
Curr Pharm Des; 2017; 23(34):5191-5199. PubMed ID: 28891448
[TBL] [Abstract][Full Text] [Related]
7. Pathways in pulmonary arterial hypertension: the future is here.
Sitbon O; Morrell N
Eur Respir Rev; 2012 Dec; 21(126):321-7. PubMed ID: 23204120
[TBL] [Abstract][Full Text] [Related]
8. An evidence-based approach to the management of pulmonary arterial hypertension.
Archer SL; Michelakis ED
Curr Opin Cardiol; 2006 Jul; 21(4):385-92. PubMed ID: 16755209
[TBL] [Abstract][Full Text] [Related]
9. Treatment of pulmonary hypertension.
Hoeper MM; McLaughlin VV; Dalaan AM; Satoh T; Galiè N
Lancet Respir Med; 2016 Apr; 4(4):323-36. PubMed ID: 26975811
[TBL] [Abstract][Full Text] [Related]
10. Selexipag for the treatment of pulmonary arterial hypertension.
Sharma K
Expert Rev Respir Med; 2016; 10(1):1-3. PubMed ID: 26567613
[TBL] [Abstract][Full Text] [Related]
11. Prostacyclin therapy for pulmonary arterial hypertension: new directions.
Gomberg-Maitland M; Preston IR
Semin Respir Crit Care Med; 2005 Aug; 26(4):394-401. PubMed ID: 16121316
[TBL] [Abstract][Full Text] [Related]
12. Targeting soluble guanylate cyclase for the treatment of pulmonary hypertension.
Lasker GF; Maley JH; Pankey EA; Kadowitz PJ
Expert Rev Respir Med; 2011 Apr; 5(2):153-61. PubMed ID: 21510726
[TBL] [Abstract][Full Text] [Related]
13. [Update: Current clinical developments in pulmonary hypertension].
Dumitrescu D; Ghofrani HA; Grimminger F; Hoeper MM; Rosenkranz S
Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S160-3. PubMed ID: 19718605
[TBL] [Abstract][Full Text] [Related]
14. Selexipag: A Review in Pulmonary Arterial Hypertension.
Duggan ST; Keam SJ; Burness CB
Am J Cardiovasc Drugs; 2017 Feb; 17(1):73-80. PubMed ID: 27988834
[TBL] [Abstract][Full Text] [Related]
15. Existing drugs and agents under investigation for pulmonary arterial hypertension.
Sharma M; Pinnamaneni S; Aronow WS; Jozwik B; Frishman WH
Cardiol Rev; 2014; 22(6):297-305. PubMed ID: 25098201
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary arterial hypertension: a current review of pharmacological management.
Sahni S; Ojrzanowski M; Majewski S; Talwar A
Pneumonol Alergol Pol; 2016; 84(1):47-61. PubMed ID: 26693827
[TBL] [Abstract][Full Text] [Related]
17. Combination Therapy in Pulmonary Arterial Hypertension-Targeting the Nitric Oxide and Prostacyclin Pathways.
Mandras S; Kovacs G; Olschewski H; Broderick M; Nelsen A; Shen E; Champion H
J Cardiovasc Pharmacol Ther; 2021 Sep; 26(5):453-462. PubMed ID: 33836637
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary arterial hypertension: on the way to a manageable disease.
Mucke HA
Curr Opin Investig Drugs; 2008 Sep; 9(9):957-62. PubMed ID: 18729002
[TBL] [Abstract][Full Text] [Related]
19. Selexipag in the treatment of pulmonary arterial hypertension: design, development, and therapy.
Hardin EA; Chin KM
Drug Des Devel Ther; 2016; 10():3747-3754. PubMed ID: 27895464
[TBL] [Abstract][Full Text] [Related]
20. Soluble Guanylate Cyclase Stimulators and Activators: Novel Therapies for Pulmonary Vascular Disease or a Different Method of Increasing cGMP?
Koress C; Swan K; Kadowitz P
Curr Hypertens Rep; 2016 Apr; 18(5):42. PubMed ID: 27118316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
